What happens when you fail in your attempts to create a vaccine for “Covid-19” and then realize you’ve just missed out on a billion-dollar profit-making opportunity?
You hurriedly develop a new drug, rush it through a clinical trial (which you yourself design to ensure good results), and then announce it to the world as the Covid cure we’ve all been waiting for, except no one’s been waiting for it because Covid isn’t any more deadly than the flu, and can be treated by easy-to-procure, inexpensive means (if it exists at all).
But governments are too stupid to know that and you own most of the corrupt politicians making the decisions, so who cares? As long as they’re willing to invest in your new concoction, it doesn’t even have to be necessary, or safe, or effective, or ethical…
Yes, I’m talking about “Molnupiravir”, Merck’s latest poison being promoted as an effective treatment against covid-19 (hang on, I thought that’s what the vaccines were for?).
This unapproved (yes, unapproved) drug costs $700 per course and the US government has just agreed to buy 1.7m courses. That’s a 1.2 BILLION dollar investment.
The deal is part of the Biden administration’s pledge to “respond to the health needs of the public”, but, in actuality, it’s simply a money-siphoning operation, with the American public coming off second best.
Molnupiravir is being sold to the public as the next big breakthrough in Covid-19 treatment off the back of what appears to be a SINGLE study, which was never even completed. Furthermore, the study was conducted by Merck (the makers of the drug), who chose not to disclose any adverse events. If that isn’t suspicious enough, the study was never published in a peer-reviewed journal.
Media press releases are apparently the new standard when it comes to evaluating medical treatments. After all, why would you wait for independent confirmation of your results or objective peer-review when you can get paid journalists, without a shred of medical…
Read full story [icon name=”arrow-right” prefix=”fas”] Source: Molnupiravir: Covid Wonder Drug or Money-Making Scam? – OffGuardian
More stories on Molnupiravir:
Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19
Merck plans large outpatient trial of COVID-19 pill, stops study in hospitalized patients
Merck drug less effective against moderate COVID -India regulatory source
Our First Amendment rights are the pillars of our society. Freedom of speech and freedom of the press are essential.
As Americans, we each hold a tremendous responsibility to stand up for these rights. Help us spread truth and tradition by sharing The Epoch Times with your friends. Subscribe to The Epoch Times today!